Code of Massachusetts Regulations
105 CMR - DEPARTMENT OF PUBLIC HEALTH
Title 105 CMR 460.000 - Lead Poisoning Prevention And Control
EARLY DIAGNOSIS (SCREENING) PROGRAM
Section 460.060 - Reimbursement for Mandatory Screening Services

Current through Register 1537, December 20, 2024

The following blood lead screening services shall constitute the "Mandatory Blood Lead Screening" in accordance with 105 CMR 460.050 and is required to be covered under policies of insurance as provided by M.G.L. c. 175, § 47C, hospital service contracts as provided by M.G.L. c. 176A, § 8B, medical service contracts as provided by M.G.L. c. 176B, § 4C, and health maintenance contracts as provided by M.G.L. c. 176G, § 4, and shall be reimbursable:

(A) Assessment of the child for regular screening at age four, in accordance with 105 CMR 460.050(C), and assessment for high-risk screening, in accordance with 105 CMR 460.050(D).

(B) Completion of the laboratory form known as a bloodslip.

(C) Drawing of the blood specimen pursuant to 105 CMR 460.050(B).

(D) Packaging and handling of the blood specimen including postage costs for mailing the specimen to the laboratory.

(E) Analysis of the blood specimen for lead level by atomic absorption spectrophotometry or any other method approved by the Clinical Laboratory Improvement Amendments of 1988, Public Law 100-578, to § 353 of the Public Health Service Act, 42 U.S.C. 263a, and for erythrocyte protoporphyrin by fluorometry, either through the measurement of zinc protoporphyrin or by extraction.

Disclaimer: These regulations may not be the most recent version. Massachusetts may have more current or accurate information. We make no warranties or guarantees about the accuracy, completeness, or adequacy of the information contained on this site or the information linked to on the state site. Please check official sources.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.